Group One Trading
TXG icon

Group One Trading’s 10x Genomics TXG Stock Holding History

Group One Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,843
Closed -$101K – 8548
2026
Q1 		$81.6K Buy
+3,843
New +$76.8K ﹤0.01% 4907
2025
Q3 		– Sell
-2,651
Closed -$34.6K – 9188
2025
Q2 		$30.7K Buy
+2,651
New +$24.2K ﹤0.01% 5964
2025
Q1 		– Sell
-3,426
Closed -$43.2K – 8395
2024
Q4 		$49.2K Sell
3,426
-3,846
-53% -$60.7K ﹤0.01% 5069
2024
Q3 		$164K Sell
7,272
-6,601
-48% -$136K ﹤0.01% 3798
2024
Q2 		$270K Sell
13,873
-20,962
-60% -$549K ﹤0.01% 3139
2024
Q1 		$1.31M Buy
+34,835
New +$1.53M 0.01% 1851
2023
Q4 		– Sell
-3,754
Closed -$163K – 8220
2023
Q3 		$155K Buy
+3,754
New +$195K ﹤0.01% 4039
2022
Q4 		– Sell
-2,203
Closed -$72K – 8116
2022
Q3 		$63K Buy
+2,203
New +$83.9K ﹤0.01% 5213
2021
Q2 		– Sell
-76
Closed -$13.8K – 8590
2021
Q1 		$14K Buy
+76
New +$13.1K ﹤0.01% 6917
2020
Q2 		– Sell
-8,409
Closed -$655K – 6191
2020
Q1 		$524K Buy
8,409
+859
+11% +$67K ﹤0.01% 2019
2019
Q4 		$576K Buy
+7,550
New +$454K ﹤0.01% 2322

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's TXG Position: Q2 2026 in Review

Group One Trading sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 3,843 shares — an estimated $101K sold.

Group One Trading first reported a position in TXG in Q4 2019 and held it in 11 quarters. The position peaked at $1.31M in Q1 2024. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Group One Trading reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 3,843 10x Genomics shares in Q2 2026, an estimated $101K.
  • Group One Trading first reported a position in 10x Genomics in Q4 2019 and held it in 11 quarters.
  • Group One Trading's 10x Genomics position peaked at $1.31M in Q1 2024.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.